CN108653807A - 一种表层包埋干细胞可持续诱导软骨分化的高强度水凝胶的制备方法 - Google Patents
一种表层包埋干细胞可持续诱导软骨分化的高强度水凝胶的制备方法 Download PDFInfo
- Publication number
- CN108653807A CN108653807A CN201810616914.9A CN201810616914A CN108653807A CN 108653807 A CN108653807 A CN 108653807A CN 201810616914 A CN201810616914 A CN 201810616914A CN 108653807 A CN108653807 A CN 108653807A
- Authority
- CN
- China
- Prior art keywords
- stem cell
- calcium
- growth factor
- hydrogel
- casting solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 75
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 72
- 210000000845 cartilage Anatomy 0.000 title claims abstract description 51
- 230000004069 differentiation Effects 0.000 title claims abstract description 42
- 230000006698 induction Effects 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000002344 surface layer Substances 0.000 title claims abstract description 19
- 239000000243 solution Substances 0.000 claims abstract description 68
- 238000005266 casting Methods 0.000 claims abstract description 63
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000011521 glass Substances 0.000 claims abstract description 30
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 28
- 239000003102 growth factor Substances 0.000 claims abstract description 28
- 239000007864 aqueous solution Substances 0.000 claims abstract description 25
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 23
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 23
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 23
- 238000013268 sustained release Methods 0.000 claims abstract description 20
- 239000012730 sustained-release form Substances 0.000 claims abstract description 20
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims abstract description 19
- 235000012209 glucono delta-lactone Nutrition 0.000 claims abstract description 18
- 239000000182 glucono-delta-lactone Substances 0.000 claims abstract description 18
- 229960003681 gluconolactone Drugs 0.000 claims abstract description 18
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 15
- 239000004115 Sodium Silicate Substances 0.000 claims abstract description 13
- 235000019795 sodium metasilicate Nutrition 0.000 claims abstract description 13
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052911 sodium silicate Inorganic materials 0.000 claims abstract description 13
- 239000010410 layer Substances 0.000 claims abstract description 12
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 11
- 210000004027 cell Anatomy 0.000 claims abstract description 10
- 238000002791 soaking Methods 0.000 claims abstract description 8
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000661 sodium alginate Substances 0.000 claims abstract description 6
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 6
- 239000000499 gel Substances 0.000 claims description 30
- 239000000648 calcium alginate Substances 0.000 claims description 25
- 235000010410 calcium alginate Nutrition 0.000 claims description 25
- 229960002681 calcium alginate Drugs 0.000 claims description 25
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 25
- 235000012241 calcium silicate Nutrition 0.000 claims description 24
- 229960001714 calcium phosphate Drugs 0.000 claims description 21
- 229920002401 polyacrylamide Polymers 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 239000002105 nanoparticle Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 claims description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 230000000295 complement effect Effects 0.000 claims description 13
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 12
- 230000003305 autocrine Effects 0.000 claims description 12
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 12
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 12
- 210000004700 fetal blood Anatomy 0.000 claims description 12
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 210000001691 amnion Anatomy 0.000 claims description 11
- 238000010828 elution Methods 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- 229960005069 calcium Drugs 0.000 claims description 8
- 239000011575 calcium Substances 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 210000003321 cartilage cell Anatomy 0.000 claims description 8
- 230000006378 damage Effects 0.000 claims description 8
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 7
- 102000013275 Somatomedins Human genes 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 238000001338 self-assembly Methods 0.000 claims description 7
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 6
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims description 6
- 102000011117 Transforming Growth Factor beta2 Human genes 0.000 claims description 6
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims description 6
- 101800000304 Transforming growth factor beta-2 Proteins 0.000 claims description 6
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 claims description 6
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 claims description 6
- 208000027418 Wounds and injury Diseases 0.000 claims description 6
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 6
- 230000002579 anti-swelling effect Effects 0.000 claims description 6
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 6
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 238000010382 chemical cross-linking Methods 0.000 claims description 6
- 238000011065 in-situ storage Methods 0.000 claims description 6
- 208000014674 injury Diseases 0.000 claims description 6
- 230000003993 interaction Effects 0.000 claims description 6
- 229920000554 ionomer Polymers 0.000 claims description 6
- 210000004379 membrane Anatomy 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 229940079827 sodium hydrogen sulfite Drugs 0.000 claims description 6
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 229940099456 transforming growth factor beta 1 Drugs 0.000 claims description 6
- 229940072041 transforming growth factor beta 2 Drugs 0.000 claims description 6
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 claims description 5
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 235000019691 monocalcium phosphate Nutrition 0.000 claims description 5
- 159000000007 calcium salts Chemical class 0.000 claims description 4
- 239000003643 water by type Substances 0.000 claims description 4
- 102000057297 Pepsin A Human genes 0.000 claims description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- 150000003926 acrylamides Chemical class 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 229940111202 pepsin Drugs 0.000 claims description 3
- 239000008055 phosphate buffer solution Substances 0.000 claims description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002504 physiological saline solution Substances 0.000 claims description 2
- 239000008351 acetate buffer Substances 0.000 claims 1
- 238000010931 ester hydrolysis Methods 0.000 claims 1
- 108010025899 gelatin film Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract description 4
- 238000004132 cross linking Methods 0.000 abstract description 3
- 238000004804 winding Methods 0.000 abstract description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 2
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 2
- 239000003431 cross linking reagent Substances 0.000 abstract description 2
- 230000000977 initiatory effect Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- -1 polypropylene Polymers 0.000 description 5
- 210000001188 articular cartilage Anatomy 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010007710 Cartilage injury Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- NNRFRJQMBSBXGO-CIUDSAMLSA-N (3s)-3-[[2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O NNRFRJQMBSBXGO-CIUDSAMLSA-N 0.000 description 1
- 238000010146 3D printing Methods 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 101000829980 Homo sapiens Ral guanine nucleotide dissociation stimulator Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 102100023320 Ral guanine nucleotide dissociation stimulator Human genes 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000004072 osteoblast differentiation Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810616914.9A CN108653807B (zh) | 2018-06-15 | 2018-06-15 | 一种表层包埋干细胞可持续诱导软骨分化的高强度水凝胶的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810616914.9A CN108653807B (zh) | 2018-06-15 | 2018-06-15 | 一种表层包埋干细胞可持续诱导软骨分化的高强度水凝胶的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108653807A true CN108653807A (zh) | 2018-10-16 |
CN108653807B CN108653807B (zh) | 2019-10-29 |
Family
ID=63775987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810616914.9A Active CN108653807B (zh) | 2018-06-15 | 2018-06-15 | 一种表层包埋干细胞可持续诱导软骨分化的高强度水凝胶的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108653807B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110387058A (zh) * | 2019-07-24 | 2019-10-29 | 南通大学 | 一种促进细胞在水凝胶上面正常生长的方法 |
CN110862126A (zh) * | 2019-11-26 | 2020-03-06 | 天津工业大学 | 一种含磷酸银/磷酸钙的水凝胶电催化电极的制备方法 |
CN111450403A (zh) * | 2020-04-03 | 2020-07-28 | 南开大学 | 一种用于蛋白质类药物快速透皮递送的微针阵列及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102558599A (zh) * | 2012-01-16 | 2012-07-11 | 天津工业大学 | 一种表层含介孔硅胶的硅酸/海藻酸钙杂化材料的制备方法 |
CN103232989A (zh) * | 2013-04-23 | 2013-08-07 | 天津工业大学 | 一种固定化生物大分子的海藻酸盐杂化水凝胶膜及接枝材料的制备方法 |
CN103254539A (zh) * | 2013-04-23 | 2013-08-21 | 天津工业大学 | 一种高强度高韧性蛋白质分子印迹杂化凝胶膜及其制备方法 |
-
2018
- 2018-06-15 CN CN201810616914.9A patent/CN108653807B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102558599A (zh) * | 2012-01-16 | 2012-07-11 | 天津工业大学 | 一种表层含介孔硅胶的硅酸/海藻酸钙杂化材料的制备方法 |
CN103232989A (zh) * | 2013-04-23 | 2013-08-07 | 天津工业大学 | 一种固定化生物大分子的海藻酸盐杂化水凝胶膜及接枝材料的制备方法 |
CN103254539A (zh) * | 2013-04-23 | 2013-08-21 | 天津工业大学 | 一种高强度高韧性蛋白质分子印迹杂化凝胶膜及其制备方法 |
Non-Patent Citations (2)
Title |
---|
KONGYIN ZHAO等: ""Adsorption and recognition of protein molecular imprinted calcium alginate/polyacrylamide hydrogel film with good regeneration performance and high toughness"", 《REACTIVE & FUNCTIONAL POLYMERS》 * |
刘东等: ""硅酸钙-海藻酸钙复合水凝胶膜的制备及表征"", 《复合材料学报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110387058A (zh) * | 2019-07-24 | 2019-10-29 | 南通大学 | 一种促进细胞在水凝胶上面正常生长的方法 |
CN110862126A (zh) * | 2019-11-26 | 2020-03-06 | 天津工业大学 | 一种含磷酸银/磷酸钙的水凝胶电催化电极的制备方法 |
CN110862126B (zh) * | 2019-11-26 | 2021-11-09 | 天津工业大学 | 一种含磷酸银/磷酸钙的水凝胶电催化电极的制备方法 |
CN111450403A (zh) * | 2020-04-03 | 2020-07-28 | 南开大学 | 一种用于蛋白质类药物快速透皮递送的微针阵列及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108653807B (zh) | 2019-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108785743A (zh) | 一种可诱导干细胞软骨分化的双模板分子印迹高强度水凝胶的制备方法 | |
CN108653807B (zh) | 一种表层包埋干细胞可持续诱导软骨分化的高强度水凝胶的制备方法 | |
CN105126163B (zh) | 用于软骨修复的具有组织诱导性的水凝胶的制备方法 | |
Saltz et al. | Mesenchymal stem cells and alginate microcarriers for craniofacial bone tissue engineering: A review | |
Cao et al. | Bone regeneration using photocrosslinked hydrogel incorporating rhBMP-2 loaded 2-N, 6-O-sulfated chitosan nanoparticles | |
CN103877617B (zh) | 可注射蚕丝素蛋白-海藻酸盐双交联水凝胶及其制备方法和使用方法 | |
CN108714246A (zh) | 一种可与软骨下骨结合的高强度水凝胶软骨替代物的制备方法 | |
CN109021256A (zh) | 一种杂化交联和预拉伸获得低溶胀高强度水凝胶的制备方法 | |
CN106474560B (zh) | 一种用于3d生物打印的水凝胶材料及其制备方法与应用 | |
CN108659440A (zh) | 一种二次溶胀交联获得高强度水凝胶的制备方法 | |
CN103736153A (zh) | 单层及双层聚己内酯基引导组织再生膜及其制备方法 | |
JP2009542681A5 (zh) | ||
CN105936674B (zh) | 一种紫外光3d打印用海藻酸水凝胶基质的制备方法 | |
CN107213529B (zh) | 一种用于提高成骨细胞粘附和成骨性能的可降解医用高分子三维材料的制备方法 | |
CN105343926A (zh) | 一种含有纳米二氧化硅的疤痕贴及其制备方法 | |
Xu et al. | A composite deferoxamine/black phosphorus nanosheet/gelatin hydrogel scaffold for ischemic tibial bone repair | |
CN107469151A (zh) | 一种牙槽骨修复材料及其制备方法和应用 | |
CN108192427A (zh) | 多巴胺-透明质酸涂层材料、制备方法及其在促进牙髓干细胞特异性粘附牙本质方面的应用 | |
CN108714245B (zh) | 一种可持续诱导软骨分化并与骨基底连接的水凝胶的制备方法 | |
Wang et al. | Hydrogels for treatment of different degrees of osteoarthritis | |
CN103721293A (zh) | 活性因子可控释放的光交联多层梯度水凝胶及制备方法 | |
CN105031729B (zh) | 一种真皮组织仿生海绵的制备方法 | |
CN108721692A (zh) | 一种表层包埋细胞的高强度水凝胶的制备方法 | |
Wang et al. | Cryoprinting of nanoparticle-enhanced injectable hydrogel with shape-memory properties | |
CN108295029B (zh) | 一种注射用多功能复合型水凝胶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230105 Address after: Room 303, Unit 2, Building 24, Chaohui Fourth District, Xiacheng District, Hangzhou City, Zhejiang Province, 310000 Patentee after: Cao Zhehou Address before: No. 399 Bingshui Road, Xiqing District, Tianjin, Tianjin Patentee before: TIANJIN POLYTECHNIC University |
|
TR01 | Transfer of patent right |
Effective date of registration: 20230309 Address after: 130216 group 7, Helong Town Street, Nong'an County, Changchun City, Jilin Province Patentee after: Zhou Guoli Address before: Room 303, Unit 2, Building 24, Chaohui Fourth District, Xiacheng District, Hangzhou City, Zhejiang Province, 310000 Patentee before: Cao Zhehou |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230423 Address after: Room 526, 5th Floor, Building 1, No. 6 Kangye Road, Zhujiajiao Town, Qingpu District, Shanghai, 201713 Patentee after: Shanghai Wuxin Dacheng Medical Technology (Group) Co.,Ltd. Address before: 130216 group 7, Helong Town Street, Nong'an County, Changchun City, Jilin Province Patentee before: Zhou Guoli |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: Room 526, 5th Floor, Building 1, No. 6 Kangye Road, Zhujiajiao Town, Qingpu District, Shanghai, 201713 Patentee after: Shanghai Wuxin Medical Technology Group Co.,Ltd. Country or region after: China Address before: Room 526, 5th Floor, Building 1, No. 6 Kangye Road, Zhujiajiao Town, Qingpu District, Shanghai, 201713 Patentee before: Shanghai Wuxin Dacheng Medical Technology (Group) Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |